These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8927870)

  • 61. Profiles of the Endocrine Clinic: the Mayo Clinic.
    Brennan MD; Miner KM; Rizza RA
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3427-34. PubMed ID: 9768642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Progestins and osteoporosis. Does progestin contribute to the effectiveness of estrogen replacement therapy in menopause?].
    Lopes P
    Rev Fr Gynecol Obstet; 1995; 90(5-6):307-8. PubMed ID: 7569595
    [No Abstract]   [Full Text] [Related]  

  • 64. Estrogen therapy in postmenopausal osteoporosis. What we know and what we don't.
    Roux C
    Rev Rhum Engl Ed; 1997 Jun; 64(6):402-9. PubMed ID: 9513613
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Managing endocrine and metabolic problems in the patient with advanced cancer.
    Segaloff A
    JAMA; 1981 Jan; 245(2):177-9. PubMed ID: 7452837
    [No Abstract]   [Full Text] [Related]  

  • 66. [Experience in and evaluation of estrogen replacement therapy].
    Wu H
    Zhonghua Nei Ke Za Zhi; 1997 Dec; 36(12):795-6. PubMed ID: 10451930
    [No Abstract]   [Full Text] [Related]  

  • 67. Alendronate in the treatment of osteoporosis.
    Adami S
    Aging (Milano); 1998 Apr; 10(2):159-60. PubMed ID: 9666215
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment options for postmenopausal osteoporosis.
    Singer F
    Hawaii Med J; 1994 Sep; 53(9):256-7, 260-1. PubMed ID: 7960721
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effects of SERMs on bone health. Efficacy of SERM for incidence of fractures in osteoporotic patients with lifestyle-related diseases].
    Sakai A; Nakamura T
    Clin Calcium; 2010 Mar; 20(3):322-9. PubMed ID: 20190361
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gynaecological endocrinology. Preface.
    Crosignani PG; Vercellini P
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):233. PubMed ID: 18032115
    [No Abstract]   [Full Text] [Related]  

  • 71. [Therapy of neurologic syndromes in endocrine diseases].
    Weingarten K
    Bibl Psychiatr Neurol; 1969; 139():243-76. PubMed ID: 5406904
    [No Abstract]   [Full Text] [Related]  

  • 72. Trends in the exploration of therapeutic targets for the treatment of endocrine, metabolic and immune disorders.
    Chen X; Zheng CJ; Han LY; Xie B; Chen YZ
    Endocr Metab Immune Disord Drug Targets; 2007 Sep; 7(3):225-31. PubMed ID: 17897049
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Everything old is new again.
    Hardy SE
    J Gerontol A Biol Sci Med Sci; 2009 Jan; 64(1):149. PubMed ID: 19164268
    [No Abstract]   [Full Text] [Related]  

  • 74. Glucocrinology.
    Kalra S; Priya G; Gupta Y
    J Pak Med Assoc; 2018 Jun; 68(6):963-965. PubMed ID: 30323371
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacotherapeutics and the endocrine system: blocking, replacing and exploiting nature's magic bullets.
    Dayan CM; Lightman SL
    Curr Opin Pharmacol; 2002 Dec; 2(6):691-3. PubMed ID: 12482732
    [No Abstract]   [Full Text] [Related]  

  • 76. [New advances in drug therapy in 2003-2004].
    Scheen AJ
    Rev Med Liege; 2004 Jun; 59(6):385-402. PubMed ID: 15346977
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010-2019.
    Liu X; Wu S; Sun J; Ni S; Lu L; Hu W; Wei H; Zou Y; Li T; Li J; Mijiti B; Fang P; Zhao L; Zhou H; Xing X; Niu H; Cao Y
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00729. PubMed ID: 33660404
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Research in endocrinology: a report from the Endocrine Society's 89th annual meeting.
    Rabasseda X
    Timely Top Med Cardiovasc Dis; 2007 Aug; 11():E20. PubMed ID: 18297151
    [No Abstract]   [Full Text] [Related]  

  • 79. Metabolic, endocrine, and drug-induced interference with pituitary function tests: a review.
    Cohen KL
    Metabolism; 1977 Oct; 26(10):1165-77. PubMed ID: 19680
    [No Abstract]   [Full Text] [Related]  

  • 80. [Summary of the 12th national conference on pediatric endocrine, genetic and metabolic diseases].
    Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, The Society of Pediatrics, Chinese Medical Association The Editorial Board, Chinese Journal of Pediatrics
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):638-40. PubMed ID: 24225301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.